Navigation Links
The Quigley Corporation Reports First Quarter 2009 Results
Date:5/1/2009

rvations obtained from the study relate to positive effect on nerve functioning, the Company may, in the future, be focusing on a broader therapeutic area.

The World Health Organization estimates, more than 171 million people have diabetes worldwide. It is also estimated that 20 million people, representing approximately 7% of the United States population have diabetes of which some 60% will suffer from mild to severe nerve damage due to Diabetic Peripheral Neuropathy. Conditions associated with Diabetic Peripheral Neuropathy include numbness, skin ulcers, constant pain or extreme sensitivity to stimulus.

The Quigley Corporation makes no representation that the US Food and Drug Administration or any other regulatory agency will allow this Investigational New Drug to be marketed. Furthermore, no claim is made that potential medicine discussed herein is safe, effective, or approved by the Food and Drug Administration.

Additionally, data that demonstrates activity or effectiveness in animals or in vitro tests do not necessarily mean the formula test compound; referenced herein will be effective in humans. Safety and effectiveness in humans will have to be demonstrated by means of adequate and well-controlled clinical studies before the clinical significance of the formula test compound is known. Readers should carefully review the risk factors described in filings the Company files from time to time with the Securities and Exchange Commission.

About The Quigley Corporation

The Quigley Corporation (Nasdaq: QGLY, http://www.Quigleyco.com) is a diversified natural health medical science company. Its Cold Remedy segment is a leading marketer and manufactur
'/>"/>

SOURCE The Quigley Corporation
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine news :

1. Unexpected Positive Finding Expands Potential for Quigley QR333 Drug for Diabetic Neuropathy; Findings Suggest Possible Disease Modification
2. The Quigley Corporation Reports Fourth Quarter and 2008 Annual Results; Continues To Invest In Pharmaceutical R&D Future
3. Quigley Announces Completion of Phase IIb Clinical Study of QR-333 For Diabetic Peripheral Neuropathy on November 25, 2008; Collection and Evaluation of Study Data to Begin Immediately Thereafter
4. The Quigley Corporation Reports Third Quarter 2008 Results; Continues Investment in Pharmaceutical R&D Future
5. The Quigley Corporation Names Gerard M. Gleeson to Succeed Retiring George J. Longo as Chief Financial Officer and Director
6. The Quigley Corporation Reports First Quarter 2008 Results - Increases Investment in Pharmaceutical R&D Future
7. The Quigley Corporation Reports Fourth Quarter & 2007 Annual Results; Increases Investment to $6.5 million in Pharmaceutical R&D in 2007
8. The Quigley Corporation Announces Sale of Its Health and Wellness Segment
9. Providence Service Corporation to Report First Quarter 2009 Results on Wednesday, May 6th After the Market Closes
10. Protein Sciences Corporation Appoints New Board of Directors
11. Digirad Corporation Reports First Quarter 2009 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/23/2014)... (PRWEB) November 23, 2014 AngelWeddingDress.com ... worldwide a new selection of beach wedding dresses. “If ... best prices, visit AngelWeddingDress.com as soon as possible. Here ... workmanship.” The sales manager says. , Holding a big ... girl. And choosing a beautiful beach wedding dress is ...
(Date:11/23/2014)... 23, 2014 Syngenta lawsuits are now ... of farmers and agribusinesses that have allegedly incurred significant ... Agrisure Viptera and Agrisure Duracade, genetically modified (GMO) ... for sale in China. According to a report from ... ban U.S. corn imports. Because China is the third-largest ...
(Date:11/22/2014)... (PRWEB) November 23, 2014 Every year ... their communities. AlignLife experience rapid growth in the Greenville, ... very unique opportunity. AlignLife of Simpsonville will ... offices for their first annual Toy Drive. These six ... they would support with this year's toy drive. With ...
(Date:11/22/2014)... UWDress.com, a successful wedding dress shop, has released its new ... to prepare for the wedding season. All of them are ... UWDress.com is a reliable company that has many years of ... -- formal wedding guest attire. This new collection comes in ... princess. As one of the leading companies in the wedding ...
(Date:11/22/2014)... 23, 2014 Today, Dylan Queen, a ... collection of wedding dresses; the business offers a wide ... accessories for ladies worldwide, allowing them to create multiple ... the company, this new collection of chic wedding dresses ... they are offered at discounted rates now. Dylan Queen ...
Breaking Medicine News(10 mins):Health News:Beach Wedding Dresses Added to Outstanding Online Dress Company AngelWeddingDress.com 2Health News:Syngenta Lawsuits Being Investigated by Wright & Schulte LLC, Following China’s Rejection of Corn Shipments Tainted with Unapproved GMO Seed 2Health News:Syngenta Lawsuits Being Investigated by Wright & Schulte LLC, Following China’s Rejection of Corn Shipments Tainted with Unapproved GMO Seed 3Health News:Greenville Area AlignLife Offices Join Together for a Local Toy Drive 2Health News:Formal Wedding Guest Attire Added to UWDress.com 2Health News:Dylan Queen Introduces Its New Wedding Dresses 2
... EBITDA Quarter in Q3 2009PURCHASE, N.Y., May 12 ... developer and marketer of nutritional supplements under the Iceland ... manage blood sugar levels, improve cardiovascular health, enhance memory ... for the third quarter and the first nine months ...
... in email and file archiving solutions for ... management, today announces the release of the ... the award-winning MessageSolution Enterprise Email Archive at ... MessageSolution,s SaaS email archiving solution supports ...
... CCHIT recognizes its functionality; CureMD EHR v10 CCHIT 08 Certified ... ... May 12, 2009 -- The Certification Commission for Healthcare Information ... updated interoperability requirements, is a conditionally CCHIT Certified® 08 Ambulatory ...
... beneficiaries are more satisfied with their health care, and ... Americans with employer-sponsored insurance (ESI), according to a study ... Health Affairs Web site. , The study ... Biennial Health Insurance Survey, a nationally representative survey of ...
... Chemical Entity for Topical Acne Treatment in a DecadeCARLSBAD, Calif., ... has entered into a co-promotion agreement with Allergan for ... vulgaris. Representing the first new molecule in a decade approved ... patients 12 years of age and older, ACZONE(R) Gel 5% ...
... 11 Cell Therapeutics, Inc. (Nasdaq and MTA: CTIC) ... of shares of common stock at $1.25 per share and ... offering to a single institutional investor. The Company currently expects ... hand and/or cash received in connection with this offering to ...
Cached Medicine News:Health News:Nutrition 21 Announces Financial Results for Q3 Fiscal 2009 2Health News:Nutrition 21 Announces Financial Results for Q3 Fiscal 2009 3Health News:Nutrition 21 Announces Financial Results for Q3 Fiscal 2009 4Health News:Nutrition 21 Announces Financial Results for Q3 Fiscal 2009 5Health News:Nutrition 21 Announces Financial Results for Q3 Fiscal 2009 6Health News:Nutrition 21 Announces Financial Results for Q3 Fiscal 2009 7Health News:MessageSolution Releases SaaS Hosted Archiving Solution at Microsoft TechEd North America 2009 2Health News:MessageSolution Releases SaaS Hosted Archiving Solution at Microsoft TechEd North America 2009 3Health News:MessageSolution Releases SaaS Hosted Archiving Solution at Microsoft TechEd North America 2009 4Health News:MessageSolution Releases SaaS Hosted Archiving Solution at Microsoft TechEd North America 2009 5Health News:Doctors Love its Usability & CCHIT Recognizes its Functionality; CureMD EHR v10 CCHIT 08 Certified 2Health News:Doctors Love its Usability & CCHIT Recognizes its Functionality; CureMD EHR v10 CCHIT 08 Certified 3Health News:Elderly Medicare beneficiaries give their coverage higher ratings than do those with ESI 2Health News:Elderly Medicare beneficiaries give their coverage higher ratings than do those with ESI 3Health News:SkinMedica to Co-Promote ACZONE(R) (dapsone) Gel 5% to Pediatricians in the U.S. 2Health News:SkinMedica to Co-Promote ACZONE(R) (dapsone) Gel 5% to Pediatricians in the U.S. 3Health News:SkinMedica to Co-Promote ACZONE(R) (dapsone) Gel 5% to Pediatricians in the U.S. 4Health News:Cell Therapeutics, Inc. Announces Single Institutional Investor Purchases $20 Million of Common Stock and Warrants 2
(Date:11/21/2014)... 2014  PTC Therapeutics, Inc. (NASDAQ: PTCT ) ... Award for Vision, Innovation, and Leadership has been awarded to ... award recognizes an individual who has had a significant impact ... for several decades. "I am honored to ... Peltz , Ph.D., CEO of PTC Therapeutics, Inc. "When I ...
(Date:11/21/2014)... Clementia Pharmaceuticals, Inc.  announced ... has granted Orphan Medicinal Product Designation for ... the treatment of fibrodysplasia ossificans progressiva (FOP). ... disease characterized by painful, recurrent episodes of ... bone formation. This process, known as heterotopic ...
(Date:11/21/2014)... 2014  Edwards Lifesciences Corporation (NYSE: EW ... valves and hemodynamic monitoring, announced today that it will ... a strong launch of Edwards Lifesciences Foundation,s new charitable ... the global communities where its employees live and work. ... will exceed $8 million, including more than $7 million ...
Breaking Medicine Technology:PTC Therapeutics Announces CEO, Dr. Stuart Peltz Recipient of The New Jersey Technology Council's 2014 Legend of Technology Award 2PTC Therapeutics Announces CEO, Dr. Stuart Peltz Recipient of The New Jersey Technology Council's 2014 Legend of Technology Award 3Clementia Pharmaceuticals Receives EMA Orphan Medicinal Product Designation for Palovarotene for the Treatment of Fibrodysplasia Ossificans Progressiva 2Clementia Pharmaceuticals Receives EMA Orphan Medicinal Product Designation for Palovarotene for the Treatment of Fibrodysplasia Ossificans Progressiva 3Edwards Lifesciences Increases Charitable Giving In 2014 To Support Launch Of Every Heartbeat Matters 2
This fume hood features a one-piece shell molded of polyethylene with a clear acrylic panel that slides on inside tracks. It can be set in an open, closed or intermediate position....
These handy dispensers save space and organize gloves in labs and next to hand washers. Clear acrylic. Many other sizes and custom configurations available....
... Microtome is ideal for sectioning of specimens in ... Specimen rise is automatic and accurate with section ... increments of 2 microns. Will accommodate MNL ... Vibratomes Freezing Stages , ...
... Gold Package is the ultimate ... package includes the Vibratome 3000 ... starter package accessory kit, additional ... mounts 1/2" head, rotating stage, ...
Medicine Products: